Cargando…
Developing and optimizing a computable phenotype for incident venous thromboembolism in a longitudinal cohort of patients with cancer
BACKGROUND: Research on venous thromboembolism (VTE) that relies only on the International Classification of Diseases (ICD) can misclassify outcomes. Our study aims to discover and validate an improved VTE computable phenotype for people with cancer. METHODS: We used a cancer registry electronic hea...
Autores principales: | Li, Ang, da Costa, Wilson L., Guffey, Danielle, Milner, Emily M., Allam, Anthony K., Kurian, Karen M., Novoa, Francisco J., Poche, Marguerite D., Bandyo, Raka, Granada, Carolina, Wallace, Courtney D., Zakai, Neil A., Amos, Christopher I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130880/ https://www.ncbi.nlm.nih.gov/pubmed/35647478 http://dx.doi.org/10.1002/rth2.12733 |
Ejemplares similares
-
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems
por: Li, Ang, et al.
Publicado: (2023) -
Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022) -
Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients
por: Lutsey, Pamela L., et al.
Publicado: (2018) -
Autoimmune disease and risk of postpartum venous thromboembolism
por: Walker, Rob F., et al.
Publicado: (2023) -
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)